This programme provides an excellent opportunity to hear about both national and local audits recently carried out by Clinical Scientists and Medical staff working in laboratory medicine and forthcoming national audits. The programme will cover clinical perspectives on the use of B type natriuretic peptide and the clinical aspects, assessment and management of heart failure as well as sweat testing and the clinical aspects, diagnosis and recent new therapies for cystic fibrosis.

10:00  Welcome and Introduction - Dr W Wassif, National Audit Lead

10:05  National Audit of Sweat Testing for the Investigation of Cystic Fibrosis in the United Kingdom - Dr Sarah Heap, Consultant Clinical Scientist, Head of Clinical Chemistry & Director of Fetal Anomaly Screening, Birmingham Women's Hospital

10:40  Discussion

10:45  Clinical aspects, diagnosis and recent new therapies for Cystic Fibrosis - Dr Maya Desai, Consultant Respiratory Paediatrician Birmingham Children's Hospital

11:25  Discussion

11:30  Two regional audit presentations - selected from abstracts (15 minutes each)

12:00  Lunch and comfort break & ePoster Session

14:00  National Audit of B type natriuretic peptide (BNP and NT Pro BNP assays) - Dr Gareth McKeeman, Consultant Clinical Scientist Belfast Health and Social Care Trust

14:35  Discussion

14:40  Clinical aspects, assessment and management of heart failure - Professor Mark Harbinson, Consultant Cardiologist, Belfast Health and Social Care Trust.

15:20  Discussion

15:25  Clinical Perspective of forthcoming national audits (15 minutes each)
Thyroid Funcation test reference intervals in preganancy and neonates, Mr Finlay Mackenzie, Consultant Clinical Scientist, UK NEQAS Organiser and Deputy Director
National Audit of Critical Result reporting, Mr Jamie West, Biochemistry Manager, North West Anglia NHS Foundation Trust and Miss Mary Stapleton, Principal Clinical Scientist, Northern Devon Healthcare Trust

15:55  Feedback and Closing remarks - Dr W Wassif, National Audit Lead